HGYMF — Stock Film
STOCK FILMSCENE 1/11HGYMF · $43.47
Stock Expert AI presents
HGYMF
Hogy Medical Co.,Ltd
~4 min film100% real numbersplain English
WHAT DOES THIS COMPANY DO?
Hogy Medical Co.,Ltd. What it actually does.

Provides medical-use and non-woven fabric products for healthcare applications in Japan. Now — the numbers.

on the stock market since 2014
1,409 employees
$937.2M market value
Revenue last year:
$254.7M
The net profit left over:
$9.9M
Out of every $100 in sales, $4 stays as net profit.
THE SLICE THAT TURNS INTO PROFIT: 4%

This is an established company with proven profits.

THE SALES TREND
Sales are moving sideways.

No real growth (2% a year).

$237.5M
2021
2022
2023
2024
$254.7M
2025
Cash on hand:
$143.2M
Total debt:
$89.7M
The cash outweighs the debt.

If every debt were paid off today, $53.5M would still be left in the vault — a solid cushion for hard times.

THE PRICE TAG
MARKET VALUE / ANNUAL PROFIT
94.8×

The market pays 94.8× for every dollar this company earns in a year — a price that already assumes things go well.

No analyst target is on record for this company.

THE COUNCIL REVIEW
9

angles, checked one by one.

The 4 that stand out are on screen; the rest came back neutral.

The council scores out of 10; report-card grades are out of 100.

STRENGTHS
A strong cash pile8/10
WEAK SPOTS
Thin trading in the shares2/10
The stock has lost its spark3/10
Growth has stalled4/10
WORTH WATCHING

Trading Liquidity: The shares change hands too rarely for smooth trading.

THE FIVE-YEAR JOURNEY
Bumpy, but the direction is up.

The stock trades near its peak today. For long-term holders the ride has paid off so far — though past performance guarantees nothing about the future.

1
THE BRIGHT SIDE · 1/2
Strong cash, light debt

There is $143.2M in the vault; even if every debt were paid off, $53.5M would remain.

2
THE BRIGHT SIDE · 2/2
Pays a steady dividend

It pays out $0.66 per share each year — regular cash for whoever holds the stock.

1
THE RISKS · 1/2
Growth has stalled

Over the last 4 years, sales grew only 2% a year on average. At this size, speeding back up is not easy.

2
THE RISKS · 2/2
A rich price tag

The company’s market value is 95 times its annual profit. Even a small disappointment could hit the price hard.

FINALE · THE GRADE
grade pending

We don’t have a report card for this stock yet — the data isn’t mature enough to grade. No grade is information too: it means the evidence is thin.

One-line summary: few numbers, an untested story. Keep watching.

What would you like to do next?
Open the stock page →

Not covered, because the filings we hold do not carry it: earnings execution, the revenue breakdown.

This was a film — not investment advice.
Data: FMP & company filings
Sep 11, 2026 · stockexpertai.com · Stock Film